SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust ($SLV) is experiencing intense bullish momentum, driven by spot silver prices reaching new all-time highs. This rally is fueled by tightening global supply due to upcoming Chinese export restrictions, alongside booming industrial demand from EV batteries, solar, and AI data centers. The community is actively discussing a potential 'silver squeeze' and a significant re-rating of silver's value, though some anticipate a near-term pullback after its rapid ascent.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath (PATH) is trending following news of its upcoming inclusion in the S&P MidCap 400, which is driving significant community discussion around a potential "index effect" and forced buying by institutional funds. Many anticipate substantial price appreciation, with investors highlighting the company's solid fundamentals, recent profitability, and strategic positioning in the burgeoning Agentic AI sector as key long-term growth catalysts. Despite some caution regarding recent insider selling and potential short-term pullbacks, the overall sentiment remains highly bullish for this automation leader.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is capturing significant attention ahead of its CES 2026 showcase, where it aims to highlight commercial quantum computing solutions and real-world applications. The stock is generating intense debate, with bulls pointing to its unique quantum annealing capabilities and increasing institutional ownership as signs of long-term potential, while bears voice strong concerns about its high valuation, minimal revenue, and executive stock sales, labeling it a manipulated pump-and-dump.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

Gold, as represented by GLD, is trending significantly due to its relentless ascent to new all-time highs, sparking widespread debate. The community is split between those viewing it as a critical safe-haven play against currency debasement, persistent inflation, and global geopolitical tensions, and skeptics labeling it as an overheated "bubble" poised for a sharp correction. This surge, often mirroring a broader metals rally, is seen by many as a powerful indicator of underlying systemic concerns and a potential shift in trust from traditional fiat currencies towards hard assets.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending intensely due to anticipation surrounding its upcoming FDA Type B meeting for Sonelokimab in Hidradenitis Suppurativa and growing speculation of a potential acquisition, particularly by Merck. The community is actively discussing recent executive share conversions as a strategic move to prepare for a significant corporate event, fueled by strong conviction in SLK's "Best in Class" efficacy and large market potential.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is seeing a surge in conversation following significant insider buying, notably from Apple CEO Tim Cook, which investors are interpreting as a strong vote of confidence. This has fueled widespread speculation of a potential short squeeze and a "Santa rally," with the community actively debating if this marks a key turning point for the stock after a period of depressed sentiment.

Starfighters Space Inc

Starfighters Space Inc. ($FJET) is experiencing extreme volatility following its recent public listing, leading to intense debate across the community. While many anticipate a significant short squeeze opportunity due to its low float and extremely high short borrow fees, others are wary, pointing to the company's limited revenue and expressing concerns about a classic 'pump and dump' pattern.

ProShares Trust - ProShares Ultra Bitcoin ETF

ProShares Ultra Bitcoin ETF

ProShares Ultra Bitcoin ETF (BITU) is a focal point of discussion due to notable price volatility, with many users questioning rapid drops that sometimes occur even when Bitcoin appears relatively stable. Community members are actively debating the fund's leveraged nature and potential 'decay,' while many are also seizing dips, anticipating Bitcoin's broader uptrend fueled by institutional interest and new all-time highs.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is trending due to significant new orders for its advanced transceivers, including a landmark 800G deal with a major hyperscale customer for AI-driven data centers, validating its critical role in the AI infrastructure buildout. This has fueled robust community discussion, strong price momentum, and recent analyst upgrades, with many anticipating continued growth and potential for a short squeeze.

Ascent Solar Technologies, Inc. engages in the design, development, and manufacture of solar technology and power solutions for remote locations and extreme environments. It integrates photovoltaic modules into a variety of applications such as aerospace, defense, transportation, and electronic products. The company was founded by Mohan S. Misra and Joseph H. Armstrong on October 18, 2005 and is headquartered in Thornton, CO.

Ascent Solar Technologies Inc

Ascent Solar Technologies (ASTI) is experiencing a significant surge in interest driven by multiple strategic teaming agreements, including collaborations for defense, drone power, and advanced space applications such as lunar missions. The community is actively debating the stock's high volatility and considerable price potential, balancing excitement for its innovative space technology with ongoing discussions around historical dilutions and a recent private placement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Neurocrine Biosciences Provides Update on Phase 3 Study of Valbenazine in Dyskinetic Cerebral Palsy

Neurocrine Biosciences Provides Update on Phase 3 Study of Valbenazine in Dyskinetic Cerebral Palsy Neurocrine Biosciences Provides Update on Phase 3 Study of Valbenazine in Dyskinetic Cerebral Palsy...

Assenagon Asset Management S.A. Sells 13,280 Shares of Neurocrine Biosciences, Inc. $NBIX

Assenagon Asset Management S.A. cut its stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 22.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and...

Neurocrine Biosciences (NASDAQ:NBIX) Director Leslie Norwalk Sells 1,190 Shares

Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Get Free Report) Director Leslie Norwalk sold 1,190 shares of the business's stock in a transaction dated Tuesday, December 16th. The stock was sold at an...

Neurocrine Biosciences (NASDAQ:NBIX) Director Leslie Norwalk Sells 5,000 Shares

Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Get Free Report) Director Leslie Norwalk sold 5,000 shares of the stock in a transaction on Monday, December 15th. The stock was sold at an average price...

Neurocrine Biosciences (NASDAQ:NBIX) Stock Price Expected to Rise, HC Wainwright Analyst Says

HC Wainwright increased their target price on shares of Neurocrine Biosciences from $168.00 to $198.00 and gave the stock a "buy" rating in a research note on Wednesday...

Texas Permanent School Fund Corp Sells 11,976 Shares of Neurocrine Biosciences, Inc. $NBIX

Texas Permanent School Fund Corp cut its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 18.2% in the 2nd quarter, according to its most recent filing with the Securities and...

Neurocrine Biosciences Showcases R&D Transformation Driving Innovation Across Neuroscience and Endocrinology

Neurocrine Biosciences Showcases R&D Transformation Driving Innovation Across Neuroscience and Endocrinology Neurocrine Biosciences Showcases R&D Transformation Driving Innovation Across Neuroscience...

Hudson Bay Capital Management LP Has $9.75 Million Stake in Neurocrine Biosciences, Inc. $NBIX

Hudson Bay Capital Management LP trimmed its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 48.4% during the 2nd quarter, according to the company in its most...

Neurocrine Biosciences (NASDAQ:NBIX) Stock Price Expected to Rise, Mizuho Analyst Says

Mizuho upped their target price on shares of Neurocrine Biosciences from $146.00 to $175.00 and gave the company a "neutral" rating in a research note on Friday...

Boone Capital Management LLC Makes New Investment in Neurocrine Biosciences, Inc. $NBIX

Boone Capital Management LLC bought a new stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with...

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Current Price	$147.28
Prev Close	$147.53
Open	$146.42
Dividend Yield	0.00%
50-Day Moving Average	$146.29
Beta	0.70
Avg. Volume	1.1M
PE Ratio	35.17

52-Week High	$160.18
52-Week Low	$84.23
Market Capitalization	$14.71B
EPS (Annual)	$3.29
Price to Book	4.89
Revenue Per Employee	$1.31M
Enterprise Value/EBITDA	N/A

NBIX
Neurocrine Biosciences, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NBIX News

NBIXNeurocrine Biosciences, Inc.